$BCRX stock has now fallen 8% today, according to our price data from Polygon. There has been approximately $81,394,248 of trading volume.
Here is what we see in our data on $BCRX (you can track the company live on Quiver's $BCRX stock page):$BCRX Insider Trading Activity
$BCRX insiders have traded $BCRX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BCRX stock by insiders over the last 6 months:
- THERESA HEGGIE sold 70,000 shares for an estimated $595,868
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$BCRX Hedge Fund Activity
We have seen 162 institutional investors add shares of $BCRX stock to their portfolio, and 113 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. added 4,692,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $42,040,320
- AVORO CAPITAL ADVISORS LLC removed 4,200,000 shares (-48.3%) from their portfolio in Q2 2025, for an estimated $37,632,000
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 4,084,403 shares (+2103.7%) to their portfolio in Q2 2025, for an estimated $36,596,250
- UBS GROUP AG added 3,211,465 shares (+133.6%) to their portfolio in Q2 2025, for an estimated $28,774,726
- MORGAN STANLEY added 3,032,005 shares (+132.0%) to their portfolio in Q2 2025, for an estimated $27,166,764
- D. E. SHAW & CO., INC. added 2,800,365 shares (+176.2%) to their portfolio in Q2 2025, for an estimated $25,091,270
- CALIGAN PARTNERS LP removed 2,468,761 shares (-79.4%) from their portfolio in Q2 2025, for an estimated $22,120,098
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$BCRX Government Contracts
We have seen $818,178 of award payments to $BCRX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- BULK ORLADEYO PHARMACEUTICAL: $394,853
- BULK ORDER ORLADEYO FOR VETERAN CARE.: $382,300
- BEROTRALSTAT HCL 150MG CAP,ORAL (ORLADEYO).: $34,130
- BEROTRALSTAT HCL 150MG CAP,ORAL TRADE NAME: ORLADEYO 150MG CAP: $4,723
- BULK ORDER ORLADEYO: $2,170
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$BCRX Analyst Ratings
Wall Street analysts have issued reports on $BCRX in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 08/04/2025
- B of A Securities issued a "Buy" rating on 07/01/2025
- RBC Capital issued a "Outperform" rating on 06/30/2025
- Wedbush issued a "Outperform" rating on 06/30/2025
- JP Morgan issued a "Overweight" rating on 05/06/2025
- HC Wainwright & Co. issued a "Buy" rating on 05/06/2025
- Cantor Fitzgerald issued a "Overweight" rating on 04/29/2025
To track analyst ratings and price targets for $BCRX, check out Quiver Quantitative's $BCRX forecast page.
$BCRX Price Targets
Multiple analysts have issued price targets for $BCRX recently. We have seen 8 analysts offer price targets for $BCRX in the last 6 months, with a median target of $16.0.
Here are some recent targets:
- Serge Belanger from Needham set a target price of $17.0 on 08/04/2025
- Tazeen Ahmad from B of A Securities set a target price of $15.0 on 07/01/2025
- Brian Abrahams from RBC Capital set a target price of $13.0 on 06/30/2025
- Laura Chico from Wedbush set a target price of $18.0 on 06/30/2025
- Gena Wang from Barclays set a target price of $11.0 on 05/07/2025
- Jessica Fye from JP Morgan set a target price of $13.0 on 05/06/2025
- Andrew Fein from HC Wainwright & Co. set a target price of $30.0 on 05/06/2025
You can track data on $BCRX on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
